Potential applications of imaging and image-guided radiotherapy for brain metastases and glioblastoma to improve patient quality of life
- PMID: 24312897
- PMCID: PMC3832799
- DOI: 10.3389/fonc.2013.00284
Potential applications of imaging and image-guided radiotherapy for brain metastases and glioblastoma to improve patient quality of life
Abstract
Treatment of glioblastoma multiforme (GBM) and brain metastasis remains a challenge because of the poor survival and the potential for brain damage following radiation. Despite concurrent chemotherapy and radiation dose escalation, local recurrence remains the predominant pattern of failure in GBM most likely secondary to repopulation of cancer stem cells. Even though radiotherapy is highly effective for local control of radio-resistant tumors such as melanoma and renal cell cancer, systemic disease progression is the cause of death in most patients with brain metastasis. Preservation of quality of life (QOL) of cancer survivors is the main issue for patients with brain metastasis. Image-guided radiotherapy (IGRT) by virtue of precise radiation dose delivery may reduce treatment time of patients with GBM without excessive toxicity and potentially improve neurocognitive function with preservation of local control in patients with brain metastasis. Future prospective trials for primary brain tumors or brain metastasis should include IGRT to assess its efficacy to improve patient QOL.
Keywords: brain metastases; glioblastoma; image-guided radiotherapy; neurotoxicity.
Similar articles
-
The potential role of magnetic resonance spectroscopy in image-guided radiotherapy.Front Oncol. 2014 May 5;4:91. doi: 10.3389/fonc.2014.00091. eCollection 2014. Front Oncol. 2014. PMID: 24847443 Free PMC article. Review.
-
Potential applications of image-guided radiotherapy for radiation dose escalation in patients with early stage high-risk prostate cancer.Front Oncol. 2015 Feb 2;5:18. doi: 10.3389/fonc.2015.00018. eCollection 2015. Front Oncol. 2015. PMID: 25699239 Free PMC article. Review.
-
A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme.Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):743-8. doi: 10.1016/j.ijrobp.2010.10.018. Epub 2011 Jan 13. Int J Radiat Oncol Biol Phys. 2012. PMID: 21236604 Free PMC article. Clinical Trial.
-
The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.J Neurooncol. 2020 Nov;150(2):215-267. doi: 10.1007/s11060-020-03612-7. Epub 2020 Nov 19. J Neurooncol. 2020. PMID: 33215344
-
Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.Radiat Oncol. 2013 Feb 20;8:38. doi: 10.1186/1748-717X-8-38. Radiat Oncol. 2013. PMID: 23425509 Free PMC article. Clinical Trial.
Cited by
-
Effectiveness of 6D couch with daily cone beam computed tomography in reducing PTV margins for glioblastoma multiforme.J Neurosci Rural Pract. 2023 Jan-Mar;14(1):78-83. doi: 10.25259/JNRP_2_2022. Epub 2022 Oct 22. J Neurosci Rural Pract. 2023. PMID: 36891114 Free PMC article.
-
Dosimetric Deviations of Bragg-Peak Position Shifts in Uniform Magnetic Fields for Magnetic Resonance Imaging-Guiding Proton Radiotherapy: A Monte Carlo Study.Front Public Health. 2021 Aug 3;9:641915. doi: 10.3389/fpubh.2021.641915. eCollection 2021. Front Public Health. 2021. PMID: 34414150 Free PMC article.
-
In vivo localization of chronically implanted electrodes and optic fibers in mice.Nat Commun. 2020 Sep 17;11(1):4686. doi: 10.1038/s41467-020-18472-y. Nat Commun. 2020. PMID: 32943633 Free PMC article.
-
Patient expectation and experience of MR-guided radiotherapy using a 1.5T MR-Linac.Tech Innov Patient Support Radiat Oncol. 2023 Nov 25;29:100224. doi: 10.1016/j.tipsro.2023.100224. eCollection 2024 Mar. Tech Innov Patient Support Radiat Oncol. 2023. PMID: 38162695 Free PMC article.
-
Unlocking glioblastoma: breakthroughs in molecular mechanisms and next-generation therapies.Med Oncol. 2025 Jun 21;42(7):276. doi: 10.1007/s12032-025-02830-1. Med Oncol. 2025. PMID: 40542948 Free PMC article. Review.
References
-
- Gaspar LE, Scott C, Murray K, Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys (1993) 4:1001–6 - PubMed
-
- Stupp R, Heqi ME, Mason WP, van den Bent MJ, Taphoom MJ, Janger RC, et al. Effect of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol (2009) 10:459–6610.1016/S1470-2045(09)70025-7 - DOI - PubMed
-
- Souhami L, Seiferheld W, Brachman D, Podgorsack EB, Werner-Wasik M, Lustig R, et al. Randomized comparison of stereotactic radiosurgery with carmustine for patients with glioblastoma multiforme: Report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys (2004) 60:853–6010.1016/j.ijrobp.2004.04.011 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources